期刊
INDIAN JOURNAL OF PEDIATRICS
卷 75, 期 7, 页码 709-713出版社
ALL INDIA INST MEDICAL SCIENCES
DOI: 10.1007/s12098-008-0134-2
关键词
rotaviral diarrhea; Bifilac; placebo; probiotics; clinical trial report
类别
Objective. To evaluate the efficacy and safety of Bifilac (TM) on reducing the episodes ( frequency) and duration of diarrhea induced by rotaviral infection and to evaluate the efficacy of Bifilac T to ameliorate the associated symptoms like dehydration and duration of rotaviral shedding in faeces. Methods. 80 children aged between 3 months and 3 years were enrolled and divided into 2 groups, one group received standard therapy + placebo, the other group received standard therapy + probiotic ( Bifilac) randomly. Children assessed for frequency and duration of diarrhea. Degree of dehydration, duration and volume of oral rehydration salt [ORS] therapy, duration and volume of Intra venous fluids and duration of rotaviral shedding. Results. When compared to the placebo, Bifilac showed clinical as well as statistically significant reduction in Number of episodes ( frequency) of diarrhea in a day, mean duration of diarrhea ( in days) degree of dehydration, duration and volume of oral rehydration salt [ ORS] therapy, duration and volume of intravenous fluid [IVF] therapy, duration of rotaviral shedding (P < 0.01). Conclusion. The synbiotic, bifilac, appears to be a safe and very effective adjuvant in the management of acute rotaviral diarrhea.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据